HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Senior Leaders Discuss Historic 2022 And What’s To Come In New Cosmetics Regulatory Era

Executive Summary

HBW Insight spoke with the Personal Care Products Council’s Karin Ross, executive VP of government affairs, and Tom Myers, executive vice president for legal and regulatory affairs and general counsel, to discuss the Modernization of Cosmetic Regulations Act and PCPC’s role to support members’ compliance going forward.

You may also be interested in...



FDA Announces New Home For Cosmetics Under Proposed Food Program Restructuring

The agency plans to move cosmetics regulation and color certification functions out of the Center for Food Safety and Applied Nutrition and into the Office of the Chief Scientist. The Personal Care Products Council and Independent Beauty Association provide their initial reactions.

California Eyeing More Cosmetic Ingredient Bans To Align With EU

“In the absence of protective federal action, states must take charge and get toxic chemicals out of our everyday products,” says Scott Faber, senior VP of government affairs at the Environmental Working Group. EWG is sponsoring AB 496, proposed on 7 February by Democratic Assemblymember Laura Friedman.

Attorneys On Modernized Cosmetic Regulations And New Litigation Risks

Greenberg Traurig and Hogan Lovells attorneys provide first breakdowns of the game-changing Modernization of Cosmetic Regulations Act, including the potential for new lawsuits and plaintiff tactics.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel